
Second Sight Medical Products EYES
Geschäftsbericht 2025
hinzugefügt 26.03.2026
Second Sight Medical Products Langfristiger Schuldenstrom 2011-2026 | EYES
Langfristiger Schuldenstrom Jährlich Second Sight Medical Products
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.79 M | 1.35 M | 1.38 M | 955 K | 910 K | - | 237 K | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.79 M | 237 K | 1.1 M |
Langfristiger Schuldenstrom anderer Aktien in der Medizinische Geräte
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
ClearPoint Neuro
CLPT
|
694 K | $ 8.99 | -4.16 % | $ 255 M | ||
|
EDAP TMS S.A.
EDAP
|
802 K | $ 3.45 | -0.29 % | $ 129 M | ||
|
Acutus Medical
AFIB
|
718 K | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
30.7 M | $ 12.01 | -0.5 % | $ 1.62 B | ||
|
Allied Healthcare Products
AHPI
|
5.37 K | - | 3.58 % | $ 2.21 M | ||
|
FONAR Corporation
FONR
|
3.88 M | $ 18.6 | - | $ 122 M | ||
|
Bruker Corporation
BRKR
|
32.1 M | $ 36.14 | -1.65 % | $ 5.38 K | ||
|
Globus Medical
GMED
|
14.7 M | $ 90.07 | 1.66 % | $ 12.2 B | ||
|
Helius Medical Technologies
HSDT
|
45 K | $ 1.78 | -6.32 % | $ 1.08 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
14.5 M | $ 9.27 | -0.43 % | $ 714 M | ||
|
Inspire Medical Systems
INSP
|
2.16 M | $ 54.06 | -0.15 % | $ 1.59 B | ||
|
Apollo Endosurgery
APEN
|
543 K | - | - | $ 475 M | ||
|
IRIDEX Corporation
IRIX
|
699 K | $ 1.01 | 1.34 % | $ 17.1 M | ||
|
Integer Holdings Corporation
ITGR
|
9.1 M | $ 85.48 | -0.18 % | $ 2.97 B | ||
|
OrthoPediatrics Corp.
KIDS
|
3.05 M | $ 15.68 | -1.63 % | $ 368 M | ||
|
LENSAR
LNSR
|
747 K | $ 5.83 | -1.1 % | $ 69.7 M | ||
|
Medtronic PLC
MDT
|
192 M | $ 86.15 | -0.15 % | $ 111 B | ||
|
Myomo
MYO
|
495 K | $ 0.66 | -5.68 % | $ 27.6 M | ||
|
Avinger
AVGR
|
1.1 M | - | -20.74 % | $ 369 K | ||
|
Align Technology
ALGN
|
31.1 M | $ 166.53 | -3.11 % | $ 12.5 B | ||
|
Orthofix Medical
OFIX
|
3.15 M | $ 11.68 | -0.76 % | $ 463 M | ||
|
AxoGen
AXGN
|
2.35 M | $ 30.86 | -5.45 % | $ 1.42 B | ||
|
Axonics Modulation Technologies
AXNX
|
1.56 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
355 K | - | 1.37 % | $ 20.5 M | ||
|
Penumbra
PEN
|
13.8 M | $ 329.86 | - | $ 12.8 B | ||
|
Insulet Corporation
PODD
|
3 M | $ 202.45 | -0.52 % | $ 14.2 B | ||
|
Neovasc
NVCN
|
273 K | - | - | $ 111 M | ||
|
Sintx Technologies
SINT
|
398 K | $ 2.53 | - | $ 7.02 M | ||
|
Butterfly Network
BFLY
|
2.44 M | $ 4.03 | -2.54 % | $ 853 M | ||
|
Smith & Nephew plc
SNN
|
67 M | $ 31.63 | -3.06 % | $ 23.8 B | ||
|
Stryker Corporation
SYK
|
153 M | $ 330.34 | -0.59 % | $ 126 B | ||
|
Cytosorbents Corporation
CTSO
|
541 K | $ 0.59 | 0.76 % | $ 36.7 M | ||
|
Tactile Systems Technology
TCMD
|
3.2 M | $ 24.31 | -1.06 % | $ 556 M | ||
|
TELA Bio
TELA
|
524 K | $ 0.67 | 6.38 % | $ 31.5 M | ||
|
TransMedics Group
TMDX
|
3.31 M | $ 106.65 | 1.77 % | $ 3.63 B | ||
|
BIOLASE
BIOL
|
888 K | - | -13.19 % | $ 166 K | ||
|
Tandem Diabetes Care
TNDM
|
19.5 M | $ 19.31 | 0.74 % | $ 1.31 B | ||
|
Delcath Systems
DCTH
|
101 K | $ 9.64 | -0.67 % | $ 345 M | ||
|
BioSig Technologies
BSGM
|
102 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
90 M | $ 60.97 | -2.6 % | $ 90.3 B |